Dr Reddys Laboratories Share Price Today - Live Blog for May 07, 2025

Dr Reddys Laboratories Ltd's share price has fallen by -0.41%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,156.40, and market participants are assessing the implications. The stock has a PE ratio of 18.0200, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

The share price of Dr Reddys Laboratories Ltd plunged by -0.13%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,159.35, but investors are assessing whether this is a temporary dip or a long-term trend.

After a -0.07% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,160.90. The stock has a PE ratio of 18.0200, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.18% in its share price, and it currently trades at ₹1,161.75 per share. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.30% upswing and is currently trading at ₹1,163.65, indicating strong market sentiment.

Dr Reddys Laboratories Ltd stock price decreased by -0.15%, with the current market value at ₹1,160.20 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.33% increase. Presently, it is actively trading at ₹1,161.00.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.38%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,157.15 per share.

Dr Reddys Laboratories Ltd experienced a -0.59% downturn in its share price, and it's currently trading at ₹1,151.15. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd stock price decreased by -0.11%, with the current market value at ₹1,158.00 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd's share price has dropped by -0.10%, a development that warrants careful analysis. Presently trading at ₹1,159.25, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.04%, reaching the current market price of ₹1,160.50. This development underscores the stock's growing popularity.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.08% drop, and it's now trading at ₹1,160.00 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.03% uptick in its share price. As a result, it's now actively trading at ₹1,161.40 per share, making it an attractive option for investors.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.22% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,160.00 per share. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd's share price has fallen by -0.15%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,157.50, and market participants are assessing the implications. The stock has a PE ratio of 18.0200, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

The stock of Dr Reddys Laboratories Ltd suffered a -0.10% decline, and it currently trades at ₹1,159.20 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.01% increase and currently trading at ₹1,160.00 per share. Investors are taking notice of this upward momentum.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.26% increase and currently trading at ₹1,159.90 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd's share price has fallen by -0.08%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,157.95, and market participants are assessing the implications. The stock has a PE ratio of 18.0200, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Following a noteworthy 0.34% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,158.90. When it comes to valuation, this stock has a PE ratio of 18.0200, with the industry PE ratio at 34.5887.

Dr Reddys Laboratories Ltd's share price rallied by 0.43%, reaching the current market price of ₹1,155.00. This surge is indicative of the stock's recent positive performance.

With a -0.13% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,150.20. The stock is currently trading at a PE of 18.0200, while the industry PE is 34.5887, prompting investors to assess its value proposition.

With a -0.71% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,154.05. Investors should examine the factors driving this decline. The stock's PE ratio is 18.0200, whereas the industry PE ratio stands at 34.5887.

Following a noteworthy 0.38% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,162.25. When it comes to valuation, this stock has a PE ratio of 18.0200, with the industry PE ratio at 34.5887.

Dr Reddys Laboratories Ltd experienced a substantial 5.55% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,161.00, making it an appealing option for investors.